Globus Medical, Inc. (GM0N.F)
- Previous Close
48.00 - Open
47.40 - Bid 47.00 x 10000
- Ask 47.20 x 10000
- Day's Range
47.40 - 47.40 - 52 Week Range
40.80 - 56.00 - Volume
10 - Avg. Volume
0 - Market Cap (intraday)
6.359B - Beta (5Y Monthly) 1.10
- PE Ratio (TTM)
47.40 - EPS (TTM)
1.00 - Earnings Date May 2, 2024 - May 6, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
85.92
Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. It also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, the company distributes human cell, tissue, and cellular and tissue-based products. It sells its products through direct or distributor sales representatives, as well as hip and knee products through independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.
www.globusmedical.comRecent News: GM0N.F
Performance Overview: GM0N.F
Trailing total returns as of 4/19/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: GM0N.F
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: GM0N.F
Valuation Measures
Market Cap
6.44B
Enterprise Value
6.44B
Trailing P/E
47.86
Forward P/E
19.08
PEG Ratio (5yr expected)
1.73
Price/Sales (ttm)
3.74
Price/Book (mrq)
1.73
Enterprise Value/Revenue
4.11
Enterprise Value/EBITDA
18.59
Financial Highlights
Profitability and Income Statement
Profit Margin
7.83%
Return on Assets (ttm)
4.77%
Return on Equity (ttm)
4.21%
Revenue (ttm)
1.57B
Net Income Avi to Common (ttm)
122.87M
Diluted EPS (ttm)
1.00
Balance Sheet and Cash Flow
Total Cash (mrq)
517.79M
Total Debt/Equity (mrq)
13.04%
Levered Free Cash Flow (ttm)
-346.92M